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Identity 




The gene encompasses 20 kb of DNA; 11 exons (the 
first is non-coding). 
Transcription 
3.0 kb mRNA; 1179 bp open reading frame. 
Protein 
Description 
393 amino acids; 53 kDa phosphoprotein. 
Function 
Tumour suppressor gene; P53 is a transcriptional 
regulator acting as a “guardian of the genome”; in 
response to DNA damage, p53 is overexpressed and 
activates the transcription of genes such as p21 
(implicated in cell-cycle arrest) and BAX (implicated 
in apoptosis); these activations allow either the cells to 
repair DNA damage before entering further in the cell 
cycle, or to be eliminated. In both cases, the 
consequence is to prevent propogation of cells 
containing genetic alterations. 
Homology 
5 highly-conserved regions between species. The p53 
protein contains a transactivation domain, a DNA-




In Li-Fraumeni syndrome, a dominantly inherited 
disease in which affected individuals are predisposed to 
develop sarcomas, osteosarcomas, leukemias and breast
cancers at unusually early ages. 
Somatic 
P53 is mutated in about 50% of human cancers, and the 
non-mutated allele is generally lost; the frequency and 
the type of mutation may vary from one tumor type to 
another; in general, mutations are found in the central 
part (exons 4-8) of the p53 gene; these mutations are 
missense, non-sense, deletions, insertions or splicing 
mutations; there are some hot-spots for mutations at 
CpG dinucleotides at positions 175, 248, 273 and 282.
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